Generic Name: estradiol topical
Applies to estradiol topical: vaginal cream
Other dosage forms:
 Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Breast pain or tenderness; headache; hair loss; mild nausea or vomiting; spotting or breakthrough bleeding; stomach cramps or bloating.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); back pain;breast discharge or lump in the breast; calf or leg pain or swelling; chest pain; coughing up blood; dark urine; depression; dizziness; fainting; fever; memory problems; mental or mood changes; muscle pain; one-sided weakness; painful or difficult urination; persistent or severe breast pain or tenderness; persistent or severe headache, nausea, or vomiting; severe stomach pain or swelling; slurred speech; sudden shortness of breath; sunburn-like rash; swelling of hands, legs, or feet; unusual vaginal bleeding, discharge, itching, or odor; vision changes; vomiting; weakness or numbness of an arm or leg; yellowing of the skin or eyes.


Applies to estradiol topical: transdermal film extended release, vaginal cream, vaginal ring, vaginal tablet
The most commonly reported side effects were headache, leukorrhea, vaginitis, vaginal pain/discomfort, and vaginal hemorrhage.[Ref]
Common (1% to 10%): Hot flushesFrequency not reported: Deep and superficial venous thrombosis, thrombophlebitis, myocardial infarction, stroke, increase in blood pressure, congestive heart disease[Ref]
Frequency not reported: Breast cancer, endometrial cancer, ovarian cancer[Ref]
Frequency not reported: Hypersensitivity, anaphylactoid/anaphylactic reactions[Ref]
Very common (10% or more): Infection (12%)Common (1% to 10%): AllergyPostmarketing reports: Toxic shock syndrome (fever, nausea, vomiting, diarrhea, muscle pain, dizziness, faintness, or a sunburn-rash on face and body)[Ref]
Very common (10% or more): Endometrial disorder (15%), breast pain (10%)Common (1% to 10%): Urinary tract infection, leukorrhea, vaginitis, vaginal discomfort/pain, vaginal hemorrhage, asymptomatic genital bacterial growth, genital moniliasis, vulvovaginal mycotic infection, vulvovaginal pruritus, bladder discomfortFrequency not reported: Changes in vaginal bleeding pattern and abnormal withdrawal bleeding or flow, breakthrough bleeding, spotting, dysmenorrhea, increase in size of uterine leiomyomata, vaginal candidiasis, change in amount of cervical secretion, changes in cervical ectropion, application site reactions of vulvovaginal discomfort including burning and irritation, genital pruritus, endometrial hyperplasia, breast (tenderness, enlargement), nipple discharge, galactorrhea, fibrocystic breast changesPostmarketing reports: Ring adherence to the vaginal wall, genital edema, vulval disorder, micturition frequency, urethral disorder, ovarian cancer, endometrial hyperplasia, endometrial cancer, breast cancer, vaginal erosion, vaginal ulceration[Ref]
Frequency not reported: Increase or decrease in weight, reduced carbohydrate tolerance, aggravation of porphyria, hypocalcemia, increased triglyceridesPostmarketing reports: Fluid retention[Ref]
Common (1% to 10%): Abdominal pain, nausea, diarrhea, lower abdominal pain, abdominal discomfort, anorectal discomfort, dyspepsiaFrequency not reported: Vomiting, abdominal cramps, bloating, cholestatic jaundice, increased incidence of gallbladder disease, pancreatitisPostmarketing reports: Bowel obstruction, enlarged abdomen, bloating, enlargement of hepatic hemangiomas[Ref]
Frequency not reported: Increased thyroid-binding globulin (TBG) levelsPostmarketing reports: Estrogen increase[Ref]
Frequency not reported: Enlargement of hepatic hemangiomas[Ref]
Frequency not reported: Retinal vascular thrombosis, intolerance to contact lenses, steepening of corneal curvaturePostmarketing reports: Abnormal vision[Ref]
Common (1% to 10%): Flu-like symptoms, peripheral edemaFrequency not reported: Edema[Ref]
Common (1% to 10%): InsomniaUncommon (0.1% to 1%): AnxietyFrequency not reported: Changes in libidoPostmarketing reports: Depression[Ref]
Very common (10% or more): Headache (13%)Frequency not reported: Migraine, dizziness, chorea, nervousness, mood disturbances, irritability, exacerbation of epilepsy, dementia[Ref]
Common (1% to 10%): HyperhidrosisFrequency not reported: Chloasma or melasma, erythema multiforme, erythema nodosum, hemorrhagic eruption, loss of scalp hair, hirsutism, pruritus, rash, urticaria, angioedema, vascular purpuraPostmarketing reports: Pruritus ani, erythematous rash[Ref]
Common (1% to 10%): Upper respiratory tract infection, sinusitis, pharyngitisFrequency not reported: Pulmonary embolism (venous thromboembolism or VTE), exacerbation of asthma[Ref]
Common (1% to 10%): Back pain, arthritis, arthralgia, skeletal painFrequency not reported: Leg crampsPostmarketing reports: Arthropathy (including arthrosis)[Ref]
Frequency not reported: Local abrasion[Ref]
1. "Product Information. Estrace (estradiol)." Bristol-Myers Squibb, Princeton, NJ. 
2. Cerner Multum,  Inc. "Australian Product Information." O 0
3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
It is possible that some side effects of Vagifem may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
topical emulsion
